Network pharmacology: mapping the future of multi-target drug discovery

This article evaluates the computational, mechanistic, and translational dimensions of network pharmacology as an emerging paradigm in modern drug discovery. By shifting from the conventional "one drug, one target" framework toward a holistic "multi-target, multi-pathway" approach, network pharmacology utilizes systems biology, bioinformatics, and multi-omics data integration to map complex biological networks. The study examines key computational techniques—including topological network analysis, target prediction, enrichment pathways, and molecular docking—used to decipher polypharmacological mechanisms, evaluate synergistic drug combinations, and minimize off-target toxicities. Furthermore, it highlights the utility of network pharmacology in accelerating drug repurposing and understanding natural product formulations for polygenic diseases. Ultimately, this comprehensive review underscores the capacity of network pharmacology to streamline early-stage target prioritization, reduce clinical attrition, and map out the future of precision therapeutics.